In patient samples, SCN4B expression levels were downregulated in lung cancer compared with normal lung tissue, and preliminary immunohistochemical analyses in lung cancer tissue microarrays showed a tendency toward decreased protein expression in high-grade primary lung tumors and metastases (Bon et al., 2016). This evidence concerns the gene SCN4B and lung carcinoma.